Patent ID: 11858933
Assignee: LYNK PHARMACEUTICALS CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 0:
1. A compound having the structural formula (VII):, , wherein
R1 is hydrogen or C1-C6 alkyl;
each R3 is independently hydrogen or C1-C6 alkyl;
R4 is a group selected from hydrogen, halogen, CN, C1-C6 alkyl, OR′, and NHR′;
R5 is RX or NRXRY, wherein each of RX and Ry is independently selected from H, alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl and RX and Ry may together form a 4- or 5-membered ring, and each of RX and Ry is optionally substituted with one or more of halogen, CN, OR′, NR′R″, alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl and alkoxyalkyl; provided that when R5 is RX, RX is not H;
RL is (CH2)m and m is 1;
each R′ and R″ is independently selected from hydrogen and C1-C6 alkyl and R′ and R″ may together form a 3- to 7-membered ring; and
n is 1 or 2,, or a pharmaceutically acceptable salt thereof.